I am a Research Associate Professor in the Department of Emergency Medicine at the University of Michigan and a member of the Max Harry Weil Institute of Critical Care Research and Innovation. My research interests include the development of non-invasive monitoring techniques and devices, innovative resuscitative fluids and hemostatic strategies, and the testing of high-fidelity and clinically faithful preclinical models of critical care disease. I currently serve as the director of the Pre-Clinical Critical Care Laboratory (PC3L) at the Weil Institute. The PC3L provides a platform that brings together clinicians, engineers, and basic and clinical investigators to develop high-fidelity preclinical models of critical illness and injury. The PC3L impact lies in establishing the appropriate models to meet these collaborators’ research needs, especially for those with limited resources. Throughout my career, I have served and continue to serve either as a PI or Co-I on several federally and institutionally funded clinical and preclinical research projects. I also serve as a mentor for many undergraduate and graduate students and as a member of several institutional committees such as the IACUC and the Faculty Senate Research Advisory Committee (RAC).

Development of pre-clinical models to study critical care illness and injury
Development of non-invasive technologies to evaluate intravenous volume status in critically ill patients using bioimpedance
Development of non-invasive technologies to evaluate cerebrovascular autoregulation using ocular bioimpedance
Development of non-invasive spectroscopic technologies to monitor tissue oxygenation using Resonance Raman Spectroscopy (RRS)
Development of resuscitation Fluids, hemoglobin, and non-hemoglobin oxygen carriers
Development of closed-loop feedback CPR devices
Development of hemorrhage control materials and devices